University of California, San Diego (UCSD) Study Finds Potential New Drug Therapy for Crohn’s Disease  
11/30/2012 12:16:38 PM

Ustekinumab, an antibody proven to treat the skin condition psoriasis, has now shown positive results in decreasing the debilitating effects of Crohn’s Disease, according to researchers at the University of California San Diego, School of Medicine. The study will appear in the October 18, 2012 issue of the New England Journal of Medicine (NEJM).